Form 4: Newmont Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Newmont Director Bruce R. Brook sold 2,077 shares of common stock for $74.59 per share, pursuant to a pre-arranged 10b5-1 trading plan.
Summary
- Bruce R. Brook, a Director of Newmont Corp /DE/ (NEM), reported the sale of 2,077 shares of common stock.
- The transaction occurred on September 2, 2025, at a price of $74.59 per share.
- The total value of the shares sold was approximately $154,900.03.
- Following this transaction, Mr. Brook directly beneficially owns 38,949 shares of Newmont common stock.
- The sale was executed under a Rule 10b5-1 trading plan, which was established on September 3, 2024.
Sentiment
Score: 5
Explanation: A neutral score. While insider selling can be viewed negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling based on new, non-public information. The transaction size is also relatively small compared to the company's market capitalization.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reactive sale based on new, non-public information.
Negatives
- A director selling shares, even under a 10b5-1 plan, can sometimes be perceived as a lack of conviction in the company's near-term stock performance by some investors.
- The transaction reduces the director's direct beneficial ownership in the company.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Minor impact. The sale by a director could be interpreted by some as a slight negative signal, but the 10b5-1 plan reduces this concern. The number of shares sold is not significant enough to materially impact the company's stock price or float.
Key Dates
| Date | Description |
|---|---|
| 2024-09-03 | Date Rule 10b5-1 trading plan was established. |
| 2025-09-02 | Date of transaction (sale of common stock). |
| 2025-09-04 | Date Form 4 was signed and filed. |
Recommendation
holdThis Form 4 filing reports a routine, pre-scheduled insider sale under a 10b5-1 plan. Such transactions are generally not indicative of a change in the company's fundamental outlook or a significant shift in management's confidence. The volume of shares sold is also not substantial enough to warrant a change in investment recommendation based solely on this filing. Investors should continue to evaluate Newmont based on its operational performance, financial results, and broader market conditions.
Keywords
Newmont, NEM, insider trading, Form 4, director, stock sale, 10b5-1 plan, beneficial ownership, common stock, mining, gold
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.